Answer
Yes, Pentasa mesalazine is contraindicated in patients with severe liver impairment, severe kidney impairment, or both.
Sources for this answer
- Pentasa Slow Release Tablets 500mgFerring Pharmaceuticals Ltd · emc · SmPC §4.3 Contraindications · Version 22Document updated
Sources checked